Explore every episode of the podcast CEimpact Podcast
Dive into the complete episode list for CEimpact Podcast. Each episode is cataloged with detailed descriptions, making it easy to find and explore specific topics. Keep track of all episodes from your favorite podcast and never miss a moment of insightful content.
Rows per page:
50
1–50 of 391
Title
Pub. Date
Duration
Pharmacy's Role with Long-Acting Injectable Medications
17 Nov 2025
00:34:07
Discover the benefits of implementing a long-acting injectable (LAI) service at your pharmacy practice site and the impact this service can have on patient care and outcomes. Listen to this week’s episode and learn how to elevate your pharmacy services!
HOST Joshua Davis Kinsey, PharmD VP, Education CEimpact
GUEST Lindsay McCoy, PharmD, BCPP Pharmacy Manager Village Drug Shop at Advantage
CPE REDEMPTION This course is accredited for continuing pharmacy education! Click the link below that applies to you to take the exam and evaluation:
CPE INFORMATION Learning Objectives Upon successful completion of this knowledge-based activity, participants should be able to: 1. Analyze the benefits and challenges of implementing a long-acting injectable (LAI) service in a pharmacy practice site. 2. Discuss how an LAI service can improve patient care, increase financial sustainability, and optimize patient outcomes.
0.05 CEU/0.5 Hr UAN: 0107-0000-25-354-H01-P Initial release date: 11/17/2025 Expiration date: 11/17/2026 Additional CPE details can be found here.
Take your pharmacy practice to the next level with our comprehensive course on the administration of long-acting injectables: Pharmacy-Based Administration of Long-Acting Injectables: A Sharp Idea 4 hours | On Demand Explore a cutting edge clinical service opportunity with this collection of courses specifically designed to equip pharmacists with the knowledge and skills necessary for the effective management and administration of long-acting injectable medications (LAIs). Course content explores diverse drug profiles, advanced administration techniques, and the strategic implementation of LAI-related services to support the needs of your patients and communities.
Opioids remain a cornerstone of palliative care for patients with serious illnesses like cancer, yet their use is often misunderstood, undertreated, or approached with unnecessary hesitation. This episode explores what pharmacists need to know about assessing opioid appropriateness, questioning therapy when warranted, and supporting comfort-focused care within established clinical and ethical standards. Tune in to build confidence in your role and contribute meaningfully to the care of patients facing serious illness.
HOST Joshua Davis Kinsey, PharmD VP, Education CEimpact
GUEST Lorin Fisher, PharmD, BCACP Clinical Assistant Professor University of Iowa College of Pharmacy
Joshua Davis Kinsey and Lorin Fisher have no relevant financial relationships to disclose.
CPE REDEMPTION This course is accredited for continuing pharmacy education! Click the link below that applies to you to take the exam and evaluation:
CPE INFORMATION Learning Objectives Upon successful completion of this knowledge-based activity, participants should be able to: 1. Identify the role of opioids in managing pain and other symptoms for patients receiving palliative care. 2. Describe key considerations for evaluating opioid prescriptions in the context of serious illness, including appropriate use and safety concerns.
0.05 CEU/0.5 Hr UAN: 0107-0000-25-330-H01-P Initial release date: 11/10/2025 Expiration date: 11/10/2026 Additional CPE details can be found here.
As more patients live beyond cancer treatment, survivorship care is becoming an essential—but often overlooked—part of the healthcare journey. This episode explores how pharmacists can support survivors through medication management, mental health awareness, lifestyle counseling, and connection to broader care resources. Tune in to learn how you can play a meaningful role in helping patients navigate life after cancer.
HOST Joshua Davis Kinsey, PharmD VP, Education CEimpact
GUEST Erica Marchese, PharmD, BCPS, BCOP, BCSCP, MHA Clinical Pharmacy Program Director City of Hope
Joshua Davis Kinsey and Erica Marchese have no relevant financial relationships to disclose.
CPE REDEMPTION This course is accredited for continuing pharmacy education! Click the link below that applies to you to take the exam and evaluation:
CPE INFORMATION Learning Objectives Upon successful completion of this knowledge-based activity, participants should be able to: 1. Identify common physical, emotional, and medication-related challenges faced by patients in the survivorship phase of cancer care. 2. Describe the pharmacist's role in supporting survivorship through medication review, lifestyle counseling, and care coordination.
0.05 CEU/0.5 Hr UAN: 0107-0000-25-292-H01-P Initial release date: 9/15/2025 Expiration date: 9/15/2026 Additional CPE details can be found here.
Learning Objectives Upon successful completion of this knowledge-based activity, participants should be able to: 1. Discuss the OUtMATCH study results and their relevance to patients with food allergies.
2. Interpret the new AAAAI anaphylaxis guidelines in relation to patient care.
0.05 CEU/0.5 Hr UAN: 0107-0000-24-079-H01-P Initial release date: 03/18/2024 Expiration date: 03/18/2025 Additional CPE details can be found here.
Stay updated on recently FDA-approved medications crucial for pharmacists. Gain essential insights on new drugs approved in the last 12 to 18 months, ensuring accurate dispensing and effective patient education.
The GameChanger SweatControl Patch approved for primary axillary hyperhidrosis. Update in treatment for Alzheimer's with mild cognitive impairment.
Host Joe Strain, PharmD Clinical Faculty, Monument Health South Dakota State College of Pharmacy
Learning Objectives Upon successful completion of this knowledge-based activity, participants should be able to: 1. Discuss the therapeutic indications of recent FDA-approved medications. 2. Describe unique pharmacological properties for each new medication.
0.05 CEU/0.5 Hr UAN: 0107-0000-24-098-H01-P Initial release date: 03/11/2024 Expiration date: 03/11/2025 Additional CPE details can be found here.
The cardiometabolic syndrome is a concept recently developed by the American Heart Association to denote the totality of risk in a patient with risk factors that may lead to or worsen chronic kidney disease or cardiovascular events. A new validated scoring system has been endorsed by AHA to better assess the short and long-term risk for these in the general population. We will discuss this scoring system in this podcast.
The GameChanger A new validated scoring system has incorporated factors to better determine the 10 and 30 year risk of CVD and CKD in a general population.
Geoff Wall, PharmD, BCPS, FCCP, BCGP Professor of Pharmacy Practice, Drake University Internal Medicine/Critical Care, UnityPoint Health
Mathew Boyd, PharmD Clinical Pharmacist Unity Point
Learning Objectives Upon successful completion of this knowledge-based activity, participants should be able to: 1. Describe the concept of the Cardiovascular-Kidney-Metabolic syndrome. 2. Discuss how the PREVENT scoring system is applied to patients.
0.05 CEU/0.5 Hr UAN: 0107-0000-24-075-H01-P Initial release date: 3/4/2024 Expiration date: 3/4/2025 Additional CPE details can be found here.
Several outbreaks of a relatively new, resistant fungal infection - candida auris - have been reported in the Pacific Northwest. It is highly contagious and its mortality has approached 60%. Listen in as we discuss what to watch for and how to prepare if this reaches your geography.
THE GAMECHANGER: Candida auris is resistant to most antifungals, has high plasticity, and its mortality approaches 60%.
Geoff Wall, PharmD, BCPS, FCCP, BCGP Professor of Pharmacy Practice, Drake University Internal Medicine/Critical Care, UnityPoint Health
Reference Cristina ML, Spagnolo AM, Sartini M, Carbone A, Oliva M, Schinca E, Boni S, Pontali E. An Overview on Candida auris in Healthcare Settings. J Fungi (Basel). 2023 Sep 8;9(9):913. doi: 10.3390/jof9090913. PMID: 37755021; PMCID: PMC10532978.
Learning Objectives Upon successful completion of this knowledge-based activity, participants should be able to: 1. Discuss characteristics of C. auris infections that make it difficult to avoid outbreaks 2. Describe issues surrounding treatment of serious infections with C. auris
0.05 CEU/0.5 Hr UAN: 0107-0000-24-058-H01-P Initial release date: 2/26/2024 Expiration date: 2/26/2025 Additional CPE details can be found here.
Creative Ways to Engage Your Students and Residents
21 Feb 2024
00:37:35
Do you feel like it is getting more difficult to engage your students or residents on your rotation and keep them engaged? Or maybe you personally feel a little bored with the same old activities and strategies. In this episode, preceptors Beth Cady and Carrie Vogler of Southern Illinois University Edwardsville on some creative strategies they use to engage their learners.
Learning Objectives At the end of this course, preceptors will be able to: 1. Discuss barriers to effectively engaging students and residents in their experiential learning 2. Identify creative strategies for engaging students and residents to optimize their learning
0.075 CEU/0.75 Hr UAN: 0107-0000-24-059-H99-P Initial release date: 2/21/2024 Expiration date: 2/21/2027 Additional CPE details can be found here.
The speakers have no relevant financial relationships with ineligible companies to disclose.
ChatGPT 3.5 (https://chat.openai.com) was utilized in the planning of this Precept2Podcast episode.
This program has been: Approved by the Minnesota Board of Pharmacy as education for Minnesota pharmacy preceptors.
Reviewed by the Texas Consortium on Experiential Programs and has been designated as preceptor education and training for Texas preceptors.
With pockets of measles outbreaks throughout the country, we discuss the reasons and strategize ways pharmacy can impact vaccination rates in their communities.
The GameChanger Measles was essentially eliminated from the US in 2000. Now, we are seeing a resurgence of outbreaks that have prompted the CDC to issue warnings and reminders of the importance of proper vaccination.
Geoff Wall, PharmD, BCPS, FCCP, BCGP Professor of Pharmacy Practice, Drake University Internal Medicine/Critical Care, UnityPoint Health
Elizabeth Skoy, PharmD Professor North Dakota State University
Lacy Epperson, PharmD Clinical Pharmacist Mitchell’s Drug Store
Learning Objectives Upon successful completion of this knowledge-based activity, participants should be able to: 1. Describe the CDC warning about the increased incidence of measles 2. Discuss ways pharmacy can have an impact on increasing vaccination rates and decreasing measles outbreaks
0.05 CEU/0.5 Hr UAN: 0107-0000-24-057-H01-P Initial release date: 2/19/2024 Expiration date: 2/19/2025 Additional CPE details can be found here.
With record-cold temperatures in much of the United States this winter, a high number of cold injuries have been reported. This podcast discusses prevention and treatment for hypothermia and frostbite. Brrrrr!
The GameChangers:
Frostbite prevention using layers and heating measures
Hypothermia treatment using external and internal heating
Frostbite treatment with anticoagulants
Host Geoff Wall, PharmD, BCPS, FCCP, BCGP Professor of Pharmacy Practice, Drake University Internal Medicine/Critical Care, UnityPoint Health
Learning Objectives Upon successful completion of this knowledge-based activity, participants should be able to: 1. Differentiate between types of hypothermia 2. Discuss treatments for frostbite
0.05 CEU/0.5 Hr UAN: 0107-0000-24-051-H01-P Initial release date: 2/12/2024 Expiration date: 2/12/2025 Additional CPE details can be found here.
The American Diabetes Association has released the 2024 Standards of Care for people with Type 1 and Type 2 Diabetes. Join us as we talk with one of our favorite diabetes experts, Dr. Sue Cornell, about the major shifts in diabetes care that are omnipresent in this year's guideline updates.
The GameChanger Diabetes treatment is shifting to prevention and delay. After a long period of time without many advances, we are now on the brink of changing the game in diabetes care and prevention with new drugs and technologies.
Host Geoff Wall, PharmD, BCPS, FCCP, BCGP Professor of Pharmacy Practice, Drake University Internal Medicine/Critical Care, UnityPoint Health
Susan Cornell, PharmD, CDCES, FAPhA, FADCES Diabetes Care & Education Specialist Midwestern University College of Pharmacy
Learning Objectives Upon successful completion of this knowledge-based activity, participants should be able to: 1. Discuss highlights of the 2024 American Diabetes Association Standards of Care Update 2. Describe the landscape of diabetes care as it shifts to prevention and delay
0.05 CEU/0.5 Hr UAN: 0107-0000-24-050-H01-P Initial release date: 2/5/2024 Expiration date: 2/5/2025 Additional CPE details can be found here.
Join us Tuesday, February 13th from 7-9pm for our next live course: From A1C to Z: A Sweet Update on Diabetes Guidelines This course will review the latest revisions to the American Diabetes Association (ADA) Standards of Care specifically highlighting the rising rates of obesity-related to diabetes, a pressing health concern affecting millions worldwide and often referred to as "diabesity". Learners will gain insights into nuances related to medication management and therapeutic decision-making for patients with diabetes. Content will provide guidance for reviewing and crafting patient-centered treatment strategies that holistically address glucose management while fostering improvements in cardio-metabolic, kidney, liver, and cognitive health for individuals grappling with diabetes and related comorbidities.
Insulin icodec is the first class of long-acting insulin to be administered only once a week. Join host, Jen Moulton, as she discusses the safety and efficacy of insulin icodec with guest, Geoff Wall.
The GameChanger Insulin icodec is the first of the ultra long-acting insulins with once weekly dosing. Multiple clinical studies have suggested these pharmacokinetics work. A new meta-analysis suggests that insulin icodec is more effective than other basal insulins and at least as safe concerning hypoglycemia.
Jen Moulton, RPh President + Founder CEimpact
Geoff Wall, PharmD, BCPS, FCCP, BCGP Professor of Pharmacy Practice, Drake University Internal Medicine/Critical Care, UnityPoint Health
Reference Wang P, Zhang Y, Xu W, et al. Efficacy and Safety of Once-Weekly Insulin Regimes on Glycemic Control for Type 2 Diabetes: A Systematic Review and Network Meta-analysis. Diabetol Metab Syndr. 2024 Jan 3;16(1):3. doi: 10.1186/s13098-023-01240-5. PMID: 38172995; PMCID: PMC10763463.
Learning Objectives Upon successful completion of this knowledge-based activity, participants should be able to: 1. Explain the chemical and structural changes that make icodec different from other basal insulins 2. Discuss the results of the meta-analysis about insulin icodec
0.05 CEU/0.5 Hr UAN: 0107-0000-24-043-H01-P Initial release date: 1/29/2024 Expiration date: 1/29/2025 Additional CPE details can be found here.
Alcohol Use Disorder (AUD) and cirrhosis are common medical conditions with significant morbidity and mortality. Join host, Geoff Wall, as he evaluates the new American College of Gastroenterology guidelines.
The GameChanger The MELD score is now preferred over the Madrey score for assessing mortality. Baclofen is the primary treatment for reducing consumption and craving in alcohol use disorder.
Host Geoff Wall, PharmD, BCPS, FCCP, BCGP Professor of Pharmacy Practice, Drake University Internal Medicine/Critical Care, UnityPoint Health
Reference Jophlin LL, Singal AK, Bataller R, Wong RJ, Sauer BG, Terrault NA, Shah VH. ACG Clinical Guideline: Alcohol-Associated Liver Disease. Am J Gastroenterol. 2024 Jan 1;119(1):30-54. doi: 10.14309/ajg.0000000000002572. Epub 2023 Sep 1. PMID: 38174913.
Learning Objectives Upon successful completion of this knowledge-based activity, participants should be able to: 1. Discuss the initial treatment of a patient admitted with acute alcoholic hepatitis 2. Describe a pharmacotherapeutic plan for adjunctive treatment of alcohol use disorder
0.05 CEU/0.5 Hr UAN: 0107-0000-24-042-H01-P Initial release date: 1/22/2024 Expiration date: 1/22/2025 Additional CPE details can be found here.
Falls are a leading cause of injury and death in older adults, and pharmacists are in a key position to help prevent them. This episode highlights how to identify medication risks, share practical prevention strategies, and connect patients with trusted tools and resources. Tune in to learn how you can make a meaningful impact in reducing falls in your community.
HOST Joshua Davis Kinsey, PharmD VP, Education CEimpact
GUEST Kristin Meyer PharmD, BCGP, FASCP Professor of Pharmacy Practice Drake University College of Pharmacy and Health Sciences
Joshua Davis Kinsey and Kristin Meyer have no relevant financial relationships to disclose.
CPE INFORMATION Learning Objectives Upon successful completion of this knowledge-based activity, participants should be able to: 1. Identify common medication classes and household hazards associated with increased fall risk in older adults. 2. Describe the pharmacist's role in fall prevention through medication review, patient education, and community engagement.
0.05 CEU/0.5 Hr UAN: 0107-0000-25-269-H05-P Initial release date: 9/8/2025 Expiration date: 9/8/2026 Additional CPE details can be found here.
Communication is ‘an essential duty’ of a pharmacist and the cornerstone of quality patient care. And yet, it continues to be one of the most common frustrations reported by preceptors when working with students and residents. Many factors may be at play, including a pandemic, as well as a digital society where so much communication happens in quick, abbreviated bytes.
On this episode, guest Christine Klein reminds us of the many facets of communication, the complex range of reasons some students and residents may struggle, and how we as mentors and teachers can support their development in this area effectively.
Learning Objectives At the end of this course, preceptors will be able to: 1. Discuss the importance of strong communication skills for students and residents 2. Describe the preceptor's role in fostering professional communication
0.05 CEU/0.5 Hr UAN: 0107-0000-24-041-H99-P Initial release date: 1/17/2024 Expiration date: 1/17/2027 Additional CPE details can be found here.
The speakers have no relevant financial relationships with ineligible companies to disclose.
This program has been: Approved by the Minnesota Board of Pharmacy as education for Minnesota pharmacy preceptors.
Reviewed by the Texas Consortium on Experiential Programs and has been designated as preceptor education and training for Texas preceptors.
Hyponatremia is a side effect of most diuretics but the incidence from thiazides is unknown. Join host, Geoff Wall, as he evaluates a new study from Denmark evaluating hyponatremia and thiazides.
The GameChanger Thiazide diuretics are considered first-line therapy but electrolyte side effects are underevaluated. A new study suggests hyponatremia is significantly more common than previously reported, especially in the elderly.
Host Geoff Wall, PharmD, BCPS, FCCP, BCGP Professor of Pharmacy Practice, Drake University Internal Medicine/Critical Care, UnityPoint Health
Reference Andersson NW, Wohlfahrt J, Feenstra B, et al. Cumulative Incidence of Thiazide-Induced Hyponatremia: A Population-Based Cohort Study. Ann Intern Med. 2023 Dec 19. doi: 10.7326/M23-1989. Epub ahead of print. PMID: 38109740.
Learning Objectives Upon successful completion of this knowledge-based activity, participants should be able to: 1. Discuss the use of thiazides in hypertension and their adverse effects 2. Assess the strengths and weaknesses of the Andersson et al study
0.05 CEU/0.5 Hr UAN: 0107-0000-24-032-H01-P Initial release date: 1/15/2024 Expiration date: 1/15/2025 Additional CPE details can be found here.
Sickle cell disease (SCD) is a devastating medical condition causing pain, fatigue, and early mortality. Join host, Geoff Wall, as he evaluates a new gene therapy via CRISPR that may cure SCD.
The GameChanger CRISPR is a new method to develop targeted gene editing treatments. Lovo-cel is the first FDA-approved therapy and may treat sickle cell disease (SCD) - for only $2 million.
Host Geoff Wall, PharmD, BCPS, FCCP, BCGP Professor of Pharmacy Practice, Drake University Internal Medicine/Critical Care, UnityPoint Health
Learning Objectives Upon successful completion of this knowledge-based activity, participants should be able to: 1. Discuss what CRISPR is and how it can be used to treat diseases 2. Describe the use of lovotibeglogene autotemcel (lovo-cel) for sickle cell disease and its safety and efficacy data
0.05 CEU/0.5 Hr UAN: 0107-0000-24-031-H01-P Initial release date: 1/8/2024 Expiration date: 1/8/2025 Additional CPE details can be found here.
Atrial fibrillation is the most common clinical arrhythmia. The newest guidelines have significant changes in diagnosis, assessment, and treatment. Join host, Geoff Wall, with guest Matt Boyd, as they evaluate the pharmacotherapy changes in the new guidelines in this two-part episode.
The GameChanger Rate and rhythm control medications largely have the same clinical outcomes. Patients with heart failure with reduced ejection fraction should try rhythm control first. Monitoring is key for atrial fibrillation pharmacotherapy.
Host Geoff Wall, PharmD, BCPS, FCCP, BCGP Professor of Pharmacy Practice, Drake University Internal Medicine/Critical Care, UnityPoint Health
Guest Mathew Boyd, PharmD Clinical Pharmacist Unity Point
Reference Joglar JA, Chung MK, Armbruster AL, et al. 2023 ACC/AHA/ACCP/HRS Guideline for the Diagnosis and Management of Atrial Fibrillation: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines. J Am Coll Cardiol. 2023 Nov 23:S0735-1097(23)06465-3. doi: 10.1016/j.jacc.2023.08.017. Epub ahead of print. PMID: 38043043.
Learning Objectives Upon successful completion of this knowledge-based activity, participants should be able to: 1. Discuss rate versus rhythm control in patients with atrial fibrillation 2. Develop a monitoring plan and selection of medications in rhythm control
0.05 CEU/0.5 Hr UAN: 0107-0000-24-030-H01-P Initial release date: 1/5/2024 Expiration date: 1/5/2025 Additional CPE details can be found here.
Atrial fibrillation is the most common clinical arrhythmia. The newest guidelines have significant changes in diagnosis, assessment, and treatment. Join host, Geoff Wall, as he evaluates the first half of the guidelines in this two-part episode.
The GameChanger Different stratifying types of atrial fibrillation no longer exist. Additionally, left atrial occlusive devices are now recommended as first-line therapy for the prevention of stroke, though anticoagulants are the treatment of choice.
Host Geoff Wall, PharmD, BCPS, FCCP, BCGP Professor of Pharmacy Practice, Drake University Internal Medicine/Critical Care, UnityPoint Health
Reference Joglar JA, Chung MK, Armbruster AL, et al. 2023 ACC/AHA/ACCP/HRS Guideline for the Diagnosis and Management of Atrial Fibrillation: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines. J Am Coll Cardiol. 2023 Nov 23:S0735-1097(23)06465-3. doi: 10.1016/j.jacc.2023.08.017. Epub ahead of print. PMID: 38043043.
Learning Objectives Upon successful completion of this knowledge-based activity, participants should be able to: 1. Describe new definitions of atrial fibrillation and risk factors for stroke 2. Discuss mechanical prevention of stroke in high risk patients
0.05 CEU/0.5 Hr UAN: 0107-0000-23-401-H01-P Initial release date: 12/25/2023 Expiration date: 12/25/2024 Additional CPE details can be found here.
Revolutionizing Healthcare with Pharmacogenomic Testing
20 Dec 2023
00:24:01
Join Ashlee as she talks with Ina, the Director of Clinical Operations at RxGenomix, about the fascinating world of pharmacogenomics. Throughout this episode, Ashlee and Ina get into the nitty-gritty of pharmacogenomic testing - a game-changer in ensuring the right medication is administered to the right patient at the right time and dose.
Listen to this episode to equip yourself with the knowledge to grasp the potential and significance of pharmacogenomics in patient care. Whether a healthcare professional or simply curious, it's time to step into the future of personalized medicine.
In this episode, the two discuss: - Pharmacogenomics & their implications - The role genetics play in influencing medication responses - Integrating pharmacogenomics into routine patient care - The future of pharmacogenomics
Dr. Ina Liko received her Doctor of Pharmacy degree at the University of Illinois at Chicago where she was initially exposed to pharmacogenomics. She then completed a clinical residency program at Monroe Clinic where her research project was focused on the implementation of pharmacogenomics. After this initial exposure to the clinical application of pharmacogenomics, she gained experience in implementing it in a larger scale by completing a fellowship in the Clinical Implementation of Pharmacogenomics at the University of Colorado where she was exposed to a systematic approach of implementing pharmacogenomics in various therapeutic classes. Dr. Liko now serves as the Director of Clinical Pharmacogenomics Operations at RxGenomix where she works collaboratively in a multidisciplinary team leading the clinical operations.
To learn more about CEimpact's By Design memberships, click here. To learn more about the CEimpact Advanced PGx training, click here
Artificial Intelligence: What Does it Mean for Clinical Teaching?
20 Dec 2023
00:40:45
Utter the words "Artificial Intelligence" to other preceptors and pharmacy faculty, and you might get a reaction that ranges anywhere from fear and anxiety to excitement. In this insightful discussion, we explore the fundamental question of what AI is and its diverse application in shaping the landscape of pharmacy education. Guest Tim Aungst delves into the challenges surrounding student and resident access to AI tools, shedding light on the challenges and opportunities that access brings.
Learning Objectives At the end of this course, preceptors will be able to: 1. List a primary advantage of using artificial intelligence (AI) 2. Discuss ways in which access to AI should inform teaching strategies.
0.05 CEU/0.5 Hr UAN: 0107-0000-23-402-H99-P Initial release date: 12/20/2023 Expiration date: 12/20/2024 Additional CPE details can be found here.
Dr. Schott has no relevant financial relationships with ineligible companies to disclose.
Dr. Aungst reports he is a consultant for Otsuka and an advisor for Digital Therapeutics Alliance. All relevant financial relationships have been mitigated.
This program has been: Approved by the Minnesota Board of Pharmacy as education for Minnesota pharmacy preceptors.
Reviewed by the Texas Consortium on Experiential Programs and has been designated as preceptor education and training for Texas preceptors.
One of the oldest medications in our pharmacopeia is digoxin. It may be used for atrial fibrillation and heart failure, although not as a first-line agent. Despite this, digoxin use is on the rise. Join host, Geoff Wall, as he evaluates why more prescribers are using digoxin.
The GameChanger No new randomized controlled trials have been published to justify the increased use of digoxin. However, when used, providers should routinely monitor digoxin levels.
Host Geoff Wall, PharmD, BCPS, FCCP, BCGP Professor of Pharmacy Practice, Drake University Internal Medicine/Critical Care, UnityPoint Health
Reference Gazzaniga G, Menichelli D, Scaglione F, et al. Effect of digoxin on all-cause and cardiovascular mortality in patients with atrial fibrillation with and without heart failure: an umbrella review of systematic reviews and 12 meta-analyses. Eur J Clin Pharmacol. 2023 Apr;79(4):473-483. doi: 10.1007/s00228-023-03470-y. Epub 2023 Mar 6. PMID: 36872367; PMCID: PMC10039090.
Learning Objectives Upon successful completion of this knowledge-based activity, participants should be able to: 1. Apply information on the potential uses and harms of digoxin 2. Apply a strategy for monitoring digoxin in heart failure patients
0.05 CEU/0.5 Hr UAN: 0107-0000-23-400-H01-P Initial release date: 12/18/2023 Expiration date: 12/18/2024 Additional CPE details can be found here.
Join Ashlee as she talks with Jen Moulton, the president of CEimpact, about her top five takeaways from a transformative year in pharmacy education and patient care.
Listen to this episode to reflect on, learn, and apply the biggest lessons 2023 taught us, from the every-day practices that define us to the big picture within pharmacy education that leads us.
In this episode, the two discuss: - The power of focus, prioritization, and efficient processes within CEimpact. - Technology's ever-growing influence on pharmacy education. - How building connections with clients, team members, and customers can prevent burnout and foster positivity. - CEimpact's efforts to address pharmacy burnout.
To learn more about CEimpact's By Design memberships, click here.
Association between Immunization Status and Alzheimer's Disease
11 Dec 2023
00:31:53
Alzheimer's Disease is a progressive terminal disease. Many treatments are focused on lifestyle modification to delay diagnosis and onset. Join host, Geoff Wall, with guest Jake Galdo, as they look at a new study evaluating the association between vaccines and the development of Alzheimer's Disease.
The GameChanger Postviral inflammation may play a role in the development of Alzheimer's Disease. A recent claims-based study found an association between immunization status and the development of Alzheimer's Disease.
Host Geoff Wall, PharmD, BCPS, FCCP, BCGP Professor of Pharmacy Practice, Drake University Internal Medicine/Critical Care, UnityPoint Health
Jake Galdo, PharmD, MBA, BCPS, BCGP Course Content and Developer, CEimpact Managing Network Facilitator, CPESN Health Equity CEO, Seguridad
Reference Harris K, Ling Y, Bukhbinder AS, et al. The Impact of Routine Vaccinations on Alzheimer's Disease Risk in Persons 65 Years and Older: A Claims-Based Cohort Study using Propensity Score Matching. J Alzheimers Dis. 2023;95(2):703-718. doi: 10.3233/JAD-221231. PMID: 37574727; PMCID: PMC10578243.
Learning Objectives Upon successful completion of this knowledge-based activity, participants should be able to: 1. Discuss the potential mechanisms of inflammation and viral infections with the development of Alzheimer's Disease. 2. Describe the study discussed and its application in guiding patients to receive vaccines.
0.05 CEU/0.5 Hr UAN: 0107-0000-23-367-H01-P Initial release date: 12/11/2023 Expiration date: 12/11/2024 Additional CPE details can be found here.
Timely Updates in Pharmacy-Delivered Immunization Services
01 Sep 2025
00:36:00
With shifting policies, payment models, and an unpredictable respiratory virus landscape, pharmacy teams need more than clinical updates to prepare for the upcoming immunization season. This episode explores key issues shaping immunization practice today — including policy changes, billing and documentation trends, and how teams can proactively adapt and advocate for their role. Tune in for timely insights that go beyond the clinical headlines and complement our in-depth, on-demand course, Annual Immunization Update 2025.
HOST Joshua Davis Kinsey, PharmD VP, Education CEimpact
GUEST Elizabeth Skoy, PharmD Professor North Dakota State University
Joshua Davis Kinsey and Elizabeth Skoy have no relevant financial relationships to disclose.
CPE REDEMPTION This course is accredited for continuing pharmacy education! Click the link below that applies to you to take the exam and evaluation:
CPE INFORMATION Learning Objectives Upon successful completion of this knowledge-based activity, participants should be able to: 1. Recognize recent policy and reimbursement updates that influence pharmacy-based immunization services and their potential to improve patient access to care. 2. Identify strategies pharmacy teams can use to prepare for the 2025-26 respiratory virus season in ways that support timely, equitable, and effective patient immunization.
0.05 CEU/0.5 Hr UAN: 0107-0000-25-286-H01-P Initial release date: 9/1/2025 Expiration date: 9/1/2026 Additional CPE details can be found here.
Exocrine enzyme dysfunction is far more common than many primary care practitioners realize. Using pancreatic enzymes can help with symptoms and vitamin absorption. Join host, Geoff Wall, as he reviews new guidelines on the appropriate use of pancreatic enzymes.
The GameChanger Chronic pancreatitis is the most common cause of exocrine dysfunction in adults. All pancreatic enzymes are equally effective; however, the use of pancreatic enzymes to treat chronic pain is controversial.
Host Geoff Wall, PharmD, BCPS, FCCP, BCGP Professor of Pharmacy Practice, Drake University Internal Medicine/Critical Care, UnityPoint Health
Reference Whitcomb DC, Buchner AM, Forsmark CE. AGA Clinical Practice Update on the Epidemiology, Evaluation, and Management of Exocrine Pancreatic Insufficiency: Expert Review. Gastroenterology. 2023 Nov;165(5):1292-1301. doi: 10.1053/j.gastro.2023.07.007. Epub 2023 Sep 20. PMID: 37737818.
Learning Objectives Upon successful completion of this knowledge-based activity, participants should be able to: 1. Discuss common symptoms and diagnoses associated with exocrine dysfunction. 2. Describe challenges associated with the use of pancreatic enzymes.
0.05 CEU/0.5 Hr UAN: 0107-0000-23-366-H01-P Initial release date: 12/4/2023 Expiration date: 12/4/2024 Additional CPE details can be found here.
What's Your Plan? Rethinking Professional Development for Preceptors
29 Nov 2023
00:26:41
The world of healthcare is changing and so are our students and residents. If you are in a precepting role, you are experiencing some challenges in navigating these new waters.
In this episode, Logan Murry, CPD champion, makes professional development practical, effective, and intentional. Listen in to learn how taking time to practice intentional CPD can make you a more effective, and more fulfilled preceptor.
Guest Logan T. Murry, PharmD, PhD Assistant Director of the Continuing Pharmacy Education Accreditation Program Accreditation Council for Pharmacy Education (ACPE)
Learning Objectives At the end of this course, preceptors will be able to: 1. Describe the Continuing Professional Development (CPD) cycle and its key components. 2. Articulate the value of practicing intentional CPD as a preceptor.
0.05 CEU/0.5 Hr UAN: 0107-0000-23-390-H99-P Initial release date: 11/29/2023 Expiration date: 11/29/2024 Additional CPE details can be found here.
The speakers have no relevant financial relationships with ineligible companies to disclose.
This program has been: Approved by the Minnesota Board of Pharmacy as education for Minnesota pharmacy preceptors.
Reviewed by the Texas Consortium on Experiential Programs and has been designated as preceptor education and training for Texas preceptors.
Menopausal vasomotor symptoms occur in about 80% of women and have a significant impact on quality of life. Hormone replacement therapy works well; however, it is often underused. Join host, Geoff Wall, as he evaluates Fezolinetant, a new medication to treat 'hot flashes.'
The GameChanger HRT is vastly underused in menopausal women. Gabapentin and SNRIs may help with some vasomotor symptoms. Fezolinetant is effective for hot flashes and seems to be well tolerated.
Host Geoff Wall, PharmD, BCPS, FCCP, BCGP Professor of Pharmacy Practice, Drake University Internal Medicine/Critical Care, UnityPoint Health
Reference Lederman S, Ottery FD, Cano A, et al. Fezolinetant for treatment of moderate-to-severe vasomotor symptoms associated with menopause (SKYLIGHT 1): a phase 3 randomised controlled study. Lancet. 2023 Apr 1;401(10382):1091-1102. doi: 10.1016/S0140-6736(23)00085-5. Epub 2023 Mar 13. PMID: 36924778.
Learning Objectives Upon successful completion of this knowledge-based activity, participants should be able to: 1. Discuss the pros and cons of hormone replacement therapy in women with vasomotor symptoms. 2. Discuss the role of fezolinetant for treatment of vasomotor symptoms.
0.05 CEU/0.5 Hr UAN: 0107-0000-23-365-H01-P Initial release date: 11/27/2023 Expiration date: 11/27/2024 Additional CPE details can be found here.
Respiratory failure from COVID-19 should be treated as soon as possible. Join host, Geoff Wall, as he evaluates the the role of convalescent plasma in treating patients with COVID-19 and on mechanical ventilation.
The GameChanger COVID-19 is still a significant concern acutely and for long-term complications. Convalescent plasma may benefit severely ill COVID-19 patients on mechanical ventilation and with acute respiratory distress syndrome (ARDS).
Host Geoff Wall, PharmD, BCPS, FCCP, BCGP Professor of Pharmacy Practice, Drake University Internal Medicine/Critical Care, UnityPoint Health
Reference Misset B, Piagnerelli M, Hoste E, Dardenne N, Grimaldi D, Michaux I, De Waele E, Dumoulin A, Jorens PG, van der Hauwaert E, Vallot F, Lamote S, Swinnen W, De Schryver N, Fraipont V, de Mey N, Dauby N, Layios N, Mesland JB, Meyfroidt G, Moutschen M, Compernolle V, Gothot A, Desmecht D, Taveira da Silva Pereira MI, Garigliany M, Najdovski T, Bertrand A, Donneau AF, Laterre PF. Convalescent Plasma for Covid-19-Induced ARDS in Mechanically Ventilated Patients. N Engl J Med. 2023 Oct 26;389(17):1590-1600. doi: 10.1056/NEJMoa2209502. Epub 2023 Oct 25. PMID: 37889107.
Learning Objectives Upon successful completion of this knowledge-based activity, participants should be able to: 1. Discuss the latest NIH treatment guidelines for COVID-19 patients who are hospitalized 2. Describe the use of convalescent plasma in the context of a COVID-19 treatment algorithm
0.05 CEU/0.5 Hr UAN: 0107-0000-23-354-H01-P Initial release date: 11/20/2023 Expiration date: 11/20/2024 Additional CPE details can be found here.
Pharmacy Fast Facts: Drug Information vs. RX Continuing Education
15 Nov 2023
00:25:21
Join Ashlee as she talks with Derek Borkowski, CEO and founder of Pyrls about the journey that led to the creation of Pyrls. Alongside this, Derek discusses Pyrls' partnership with CEimpact and the future of Pyrls as a company.
Pyrls is an online drug information provider that focuses on design and simplicity in their delivery of that information. Through an deeper dive into Pyrls, this episode offers up an exclusive behind-the-scenes glimpse into the future of digital health and the role of technology in the medical field.
In this episode, the two discuss: - The creation of Pyrls - Pyrls' impact on the healthcare world - Pyrls' partnership with CEimpact - The future of Pyrls
To learn more about CEimpact's By Design memberships, click here.
Piperacillin/tazobactam and vancomycin have been reported in numerous clinical trials to be associated with acute kidney injury. Comparatively, cefepime with vancomycin may increase neurotoxic effects. Join host, Geoff Wall, as he evaluates a new randomized controlled trial evaluating the safety of these medications.
The GameChanger Vancomycin, even at appropriate doses, can cause nephrotoxicity. Piperacillin/tazobactam does not seem to increase the risk of adverse kidney outcomes. However, cefepime is associated with an increased risk of neurologic toxicity.
Host Geoff Wall, PharmD, BCPS, FCCP, BCGP Professor of Pharmacy Practice, Drake University Internal Medicine/Critical Care, UnityPoint Health
Reference Tong SYC, Venkatesh B, McCreary EK. Acute Kidney Injury With Empirical Antibiotics for Sepsis. JAMA. 2023;330(16):1531–1533. doi:10.1001/jama.2023.18591
Learning Objectives Upon successful completion of this knowledge-based activity, participants should be able to: 1. Describe the risk of nephrotoxicity with piperacillin/tazobactam 2. Discuss the factors that exacerbate neurologic adverse effects with cefepime
0.05 CEU/0.5 Hr UAN: 0107-0000-23-353-H01-P Initial release date: 11/13/2023 Expiration date: 11/13/2024 Additional CPE details can be found here.
Join Ashlee as she talks with Bernadette Jakeman, an ID-HIV specialized prescribing pharmacist and associate professor at the University of New Mexico College of Pharmacy. Her expertise lies in infectious diseases and HIV, a field that she's deeply passionate about and has dedicated her career to.
Listen in as she takes us on a fascinating journey, recounting her unique trajectory in the field of pharmacy, her experiences with an HIV specialist in an outpatient setting, and the incredibly impactful work she is currently doing within the HIV community.
In this episode, the two discuss: - Bernadette's unique pharmacy career path - Bernadette's work within the HIV community - How pharmacists play a role in HIV prevention - The updated Pre-Exposure Prophylaxis guidelines
For those keen on learning more or who work in the field, Bernadette has prepared an insightful course titled "Preparing for Tomorrow: A Pharmacist Guide to HIV Prevention". So, gear up to learn, engage, and feel empowered to discuss PrEP with patients and advocate for those who need it.
To learn more about CEimpact's By Design memberships and to gain access to Bernadette's course, click here.
Polymyalgia rheumatica is a common rheumatic disorder. Steroids are the mainstay of therapy despite significant adverse reactions. Join host, Geoff Wall, as he evaluates a new treatment for PMR.
The GameChanger Sarilumab is now FDA-approved for relapsing polymyalgia rheumatica. Sarilumab can be an alternative to long-term steroid therapy or methotrexate.
Host Geoff Wall, PharmD, BCPS, FCCP, BCGP Professor of Pharmacy Practice, Drake University Internal Medicine/Critical Care, UnityPoint Health
Reference Spiera RF, Unizony S, Warrington KJ, Sloane J, Giannelou A, Nivens MC, Akinlade B, Wong W, Bhore R, Lin Y, Buttgereit F, Devauchelle-Pensec V, Rubbert-Roth A, Yancopoulos GD, Marrache F, Patel N, Dasgupta B; SAPHYR Investigators. Sarilumab for Relapse of Polymyalgia Rheumatica during Glucocorticoid Taper. N Engl J Med. 2023 Oct 5;389(14):1263-1272. doi: 10.1056/NEJMoa2303452. PMID: 37792612.
Learning Objectives Upon successful completion of this knowledge-based activity, participants should be able to: 1. Describe the diagnosis and treatment of polymyalgia rheumatica 2. Assess the SAPHYR study and the role of sarilumab for treatment of polymyalgia rheumatica
0.05 CEU/0.5 Hr UAN: 0107-0000-23-352-H01-P Initial release date: 11/6/2023 Expiration date: 11/6/2024 Additional CPE details can be found here.
Join Ashlee and Tim Ulbrich, pharmacist and founder of Your Financial Pharmacist, in this week's Level Up episode as they discuss Tim's career, advice, and resources that pharmacists can use in the journey toward attaining financial wellness.
Tim Ulbrich, pharmacist & CEO of Your Financial Pharmacist, set out to help pharmacists solve this issue by helping them develop financial planning and organization skills
In this episode, the two discuss: - How Tim's blog developed into the Your Financial Pharmacist company - Tim's best tips for pharmacists hoping to work towards financial wellness - The upcoming CEimpact By Design course 'Dollars and Sense: Guidance for Building a Strong Financial Foundation', a course that Tim helped create.
To learn more about CEimpact's By Design memberships and to gain access to Tim's course, click here.
To get in touch with Your Financial Pharmacist, click here.
There are numerous formulations of aspirin available over-the-counter often advertised to decrease gastric issues. Join host, Geoff Wall, as he evaluates a new study to see if enteric aspirin is worth the extra money and effort.
The GameChanger Buffered and coated aspirin are purported to cause fewer gastric adverse events. However, no efficacy or safety differences exist in the various formulations of aspirin.
Host Geoff Wall, PharmD, BCPS, FCCP, BCGP Professor of Pharmacy Practice, Drake University Internal Medicine/Critical Care, UnityPoint Health
Reference Sleem A, Effron MB, Stebbins A, et al. Effectiveness and Safety of Enteric-Coated vs Uncoated Aspirin in Patients With Cardiovascular Disease: A Secondary Analysis of the ADAPTABLE Randomized Clinical Trial. JAMA Cardiol. Published online October 04, 2023. doi:10.1001/jamacardio.2023.3364
Learning Objectives Upon successful completion of this knowledge-based activity, participants should be able to: 1. Discuss the history of various formulations of aspirin on the US market 2. Discuss the results and limitations of the ADAPTABLE study
0.05 CEU/0.5 Hr UAN: 0107-0000-23-331-H01-P Initial release date: 10/30/2023 Expiration date: 10/30/2024 Additional CPE details can be found here.
What Should Pharmacists Know about Low-Dose Naltrexone?
25 Aug 2025
00:33:21
Low-dose naltrexone (LDN) is generating growing interest as a potential therapy for conditions such as chronic pain and immune-related disorders. This episode offers a foundational overview of what LDN is, how it’s thought to work, where current evidence stands, and how pharmacists may encounter it in practice. Learn what pharmacists need to know to confidently approach patient questions about LDN and how it fits into current conversations in pharmacy and patient care.
HOST Joshua Davis Kinsey, PharmD VP, Education CEimpact
Joshua Davis Kinsey has no relevant financial relationships to disclose.
Michelle Moser was a volunteer board member for LDN Research Trust (ended June 2025), a board member for Alliance for Pharmacy Compounding (ended September 2024), and an employee of Revelation Pharma (ended June 2024). All relevant financial relationships have been mitigated.
CPE REDEMPTION This course is accredited for continuing pharmacy education! Click the link below that applies to you to take the exam and evaluation:
CPE INFORMATION Learning Objectives Upon successful completion of this knowledge-based activity, participants should be able to: 1. Define low-dose naltrexone (LDN) and describe how it differs from traditional naltrexone dosing. 2. Identify proposed mechanisms of action and areas of emerging interest related to LDN use in practice.
0.05 CEU/0.5 Hr UAN: 0107-0000-25-275-H01-P Initial release date: 8/25/2025 Expiration date: 8/25/2026 Additional CPE details can be found here.
Ever imagine what it's like to evolve from a retail pharmacy worker to a celebrated pharmacy technician trainer?
Join Ashlee as she talks with Nicole Foster, the manager of pharmacy technician and client education at CEimpact about her inspiring journey.
During this episode, the two discuss - Nicole's career and mentors - The essential shift in the perceptions surrounding pharmacy technicians - Nicole's predictions about the future of pharmacy technicians
To learn more about our Pharmacist by Design membership, click here.
Hypertensive urgency - asymptomatic patients with elevated blood pressure - is frequently treated in the hospital and outpatient setting. Join host, Geoff Wall, as he critically examines the evidence to assess risk over benefit.
The GameChanger Treatment of asymptomatic hypertension has not been shown to improve clinical outcomes. Recent data highlights the risk with increased mortality through aggressive management.
Host Geoff Wall, PharmD, BCPS, FCCP, BCGP Professor of Pharmacy Practice, Drake University Internal Medicine/Critical Care, UnityPoint Health
Reference Anderson TS, Herzig SJ, Jing B, et al. Clinical Outcomes of Intensive Inpatient Blood Pressure Management in Hospitalized Older Adults. JAMA Intern Med. 2023;183(7):715–723. doi:10.1001/jamainternmed.2023.1667
Learning Objectives Upon successful completion of this knowledge-based activity, participants should be able to: 1. Explain the difference between hypertensive urgency and emergency 2. Discuss recent data about the possible harms of treating asymptomatic hypertension in the hospital setting
0.05 CEU/0.5 Hr UAN: 0107-0000-23-330-H01-P Initial release date: 10/23/2023 Expiration date: 10/23/2024 Additional CPE details can be found here.
The Evolution & Career Advancement of the Pharmacy Technician
18 Oct 2023
00:30:59
Ever wonder about the journeys behind the professionals working to advance in the pharmacy technician field?
Join Ashlee as she talks with Liza Chapman, the Chief Professional Officer at the PTCB (Pharmacy Technician Certification Board), and Zachary Hall, the Associate Director of Professional Affairs about professional evolution in the pharmacy technician world.
During this episode, the three discuss: - Liza & Zachary's professional journeys - The PTCB's work in progressing the pharmacy technician profession - The relationship between PTCB and P-TEC (Pharmacy Technician Educators Council) - The relationship between PTCB and CEimpact!
To learn more about our Pharmacist by Design membership, click here.
Think journal clubs are a heavy lift? That they can't be done in a small pharmacy environment? Worried that you don't have enough statistical savvy? Listen to this episode and you'll discover how journal clubs can be incorporated into just about any setting with some simple strategies. The value they bring is immense - NAPLEX preparation for graduating students, expanded clinical knowledge for the learner and staff, the development of confidence and communication skills in your students and residents, and much more.
In this episode, I talked with Dr. Valerie Coppenrath, a drug information guru and preceptor for both residents and students. She shares some background on the concept, and also provides us with some practical strategies for taking a more intentional approach to supporting our students and residents in their own professional identity journey. And who knows, maybe we’ll learn a little about ourselves along the way as well.
CPE Information Learning Objectives At the end of this course, preceptors will be able to: 1. Discuss the advantages and challenges with conducting a journal club in a range of pharmacy settings. 2. List strategies for effective journal club selection. 3. Describe strategies for overcoming barriers associated with setting up a successful journal club.
0.05 CEU/0.5 Hr UAN: 0107-0000-23-342-H99-P Initial release date: 10/18/2023 Expiration date: 10/18/2026 Additional CPE details can be found here.
The speakers have no relevant financial relationships with ineligible companies to disclose.
This program has been: Approved by the Minnesota Board of Pharmacy as education for Minnesota pharmacy preceptors.
Reviewed by the Texas Consortium on Experiential Programs and has been designated as preceptor education and training for Texas preceptors.
Want more information on this and related topics?
Mastering Journal Club Facilitation: A Toolkit for Engaging Learners This comprehensive collection of resources, tools, and best practice tips has been designed to help you facilitate an organized, effective, and engaging journal club experience, regardless of where you practice.
Journal Club Toolkit for Learners A companion to the toolkit for preceptors, this robust resource provides residents and students with checklists, templates, guidance on journal selection, and much more.
Biostatistics Refresher This course provides a crash course review in statistics to help you evaluate the literature and communicate its implications to providers and patients.
As always, be sure to check out the full library of courses available for preceptors on the CEimpact website. Be sure to ask your experiential program director if you are a member so that you can access it all for free AND get CE credit!
Injectable, long-acting therapy is a new frontier for hypertension management. Join host, Geoff Wall, as he evaluates zilebesiran, a hepatic angiotensinogen blocker for blood pressure control for up to six months.
The GameChanger Zilebesiran blocks the final production of angiotensinogen at the hepatic level making it safer from a renal perspective than the ACEis or ARBs. A single subcutaneous injection provides therapy for up to six months.
Host Geoff Wall, PharmD, BCPS, FCCP, BCGP Professor of Pharmacy Practice, Drake University Internal Medicine/Critical Care, UnityPoint Health
Reference Desai AS, Webb DJ, Taubel J, et al. Zilebesiran, an RNA Interference Therapeutic Agent for Hypertension. N Engl J Med. 2023 Jul 20;389(3):228-238. doi: 10.1056/NEJMoa2208391. PMID: 37467498. https://www.nejm.org/doi/full/10.1056/NEJMoa2208391
Learning Objectives Upon successful completion of this knowledge-based activity, participants should be able to: 1. Describe the mechanism of action of Zilebesiran 2. Discuss possible advantages and disadvantages of this drug in the treatment of hypertension
0.05 CEU/0.5 Hr UAN: 0107-0000-23-323-H01-P Initial release date: 10/16 /2023 Expiration date: 10/16/2024 Additional CPE details can be found here.
Establishing Your Personal Brand (and why it is important you have one!)
11 Oct 2023
00:25:58
In the competitive pharmacy world, defining and separating yourself in the profession are keys to success. Far too often we overlook the benefits that can come from establishing a personal brand in this profession - at first glance, it can be a daunting and unfamiliar task.
Join Jen Moulton, President of CEimpact, as she interviews Ashlee, VP of market strategy and the Founder and Executive Career Coach of RX Ashlee, about the process of defining oneself in their profession and how even the slightest changes in how we brand ourselves can have massive benefits on our careers.
During this episode, the two discuss: - Ashlee's experience in personal branding & career coaching - The keys to establishing an effective personal brand - How these keys can translate into career advancement opportunities
To access Ashlee's course through our Pharmacist by Design membership, click here.
COX-2 Inhibitors to Increase Effectiveness of Emergency Contraception
09 Oct 2023
00:23:28
Emergency contraception use has an effectiveness of about 70%. Join host, Geoff Wall, as he reviews new literature to see if COX-2 inhibition improves that rate.
The GameChanger Emergency contraception (EC) is safe and effective but overall efficacy rates could be better. COX-2 inhibitors may enhance the effectiveness of EC but require multiday dosing.
Host Geoff Wall, PharmD, BCPS, FCCP, BCGP Professor of Pharmacy Practice, Drake University Internal Medicine/Critical Care, UnityPoint Health
Reference Li RHW, Lo SST, Gemzell-Danielsson K, et al. Oral emergency contraception with levonorgestrel plus piroxicam: a randomised double-blind placebo-controlled trial. Lancet. 2023 Sep 9;402(10405):851-858. doi: 10.1016/S0140-6736(23)01240-0. Epub 2023 Aug 16. Erratum in: Lancet. 2023 Sep 9;402(10405):850. PMID: 37597523. https://www.thelancet.com/pdfs/journals/lancet/PIIS0140-6736(23)01240-0.pdf
Learning Objectives Upon successful completion of this knowledge-based activity, participants should be able to: 1. Describe the selection of the particular COX-2 medication used in this study 2. Discuss the implications of the COX-2 augmentation with patients
0.05 CEU/0.5 Hr UAN: 0107-0000-23-322-H01-P Initial release date: 10/9/2023 Expiration date: 10/9/2024 Additional CPE details can be found here.
Stepping up as Healthcare Advocates: The Role of the Pharmacist in Combatting the Opioid Crisis
04 Oct 2023
00:32:44
The opioid crisis is still among us. In fact, according to the CDC, Opioids were involved in more than 68,000 deaths in 2020, which was 8.5 times the number of opioid-involved overdose deaths in 1999. The rate of drug overdose deaths involving opioids remains high, and CDC continues to track opioid overdose deaths.
In this episode of the Level Up podcast, Ashlee is joined by Richard Logan, a deputy sheriff and pharmacy owner, as they dive into Dr. Logan's experience working within both sectors of the community.
Dr. Logan discusses the future in which pharmacists play a crucial role in tackling this crisis - alongside specific steps on how to reach that future.
Join us, as we explore the world of pharmacy through the eyes of a pharmacist and deputy sheriff.
To learn more about the CE’s below, enroll to be a By Design Member today!
GameChangers: Street Valium: Inadvertent Sulfonylurea Overdose
Opioids for Pain Management - Important Changes from New Guidelines
Dispensing Opioids for Pain Management
Naloxone: The Essentials of Pharmacist-initiated Dispensing
Regulatory Compliance Specialist: A Training for Pharmacy Technicians
Drug Price Negotiation by the Inflation Reduction Act
02 Oct 2023
00:29:27
The cost of medications is often attributed to a burden on healthcare - despite hospitalizations costing four times as much. Join host, Geoff Wall, as he discusses the new Inflation Reduction Act which allows the government to negotiate medication prices.
The GameChanger The US Federal Government can now negotiate with drug companies for the cost of medications. Similar to other countries, this bulk buying power can help lower medication prices for patients.
Host Geoff Wall, PharmD, BCPS, FCCP, BCGP Professor of Pharmacy Practice, Drake University Internal Medicine/Critical Care, UnityPoint Health
Learning Objectives Upon successful completion of this knowledge-based activity, participants should be able to: 1. List the 10 medications first targeted by the new legislation for negotiation 2. Describe the common arguments against this provision of the Inflation Reduction Act
0.05 CEU/0.5 Hr UAN: 0107-0000-23-321-H03-P Initial release date: 10/2/2023 Expiration date: 10/2/2024 Additional CPE details can be found here.
OTC Phenylephrine: Is it safe and effective to use?
27 Sep 2023
00:22:43
OTC Phenylephrine is in the news!
Join Ashlee and David Brushwood as they navigate the convoluted world of OTC decongestants, and the pivotal roles pharmacists play in ensuring patient safety and medication efficacy.
During this episode, the two discuss: 1. The role of the FDA in managing GRASE, Generally Recognized as Safe and Effective, medications. 2. The FDA's original decision to include oral Phenylephrine products in the OTC monograph for decongestants. 3. The CARES Act of 2020 and its impact on this efficacy and safety issue. 4. The instrumental roles of pharmacists in managing these products and providing the best options to patients.
To access the FBA briefing document on the efficiency of Oral Phenylephrine as a nasal decongestant, click here.
Regulatory Essentials for Safe and Compliant Compounding
18 Aug 2025
00:35:46
Compounded medications serve a critical role in meeting patient-specific needs, but compliance is essential to ensure safety and quality. This episode covers what pharmacists need to know about documentation, prescription validity, beyond-use dating, and common missteps that can put compliance at risk. Tune in to strengthen your compounding practices and stay aligned with current regulatory expectations.
HOST Joshua Davis Kinsey, PharmD VP, Education CEimpact
CPE INFORMATION Learning Objectives Upon successful completion of this knowledge-based activity, participants should be able to: 1. Identify key compliance requirements related to patient-specific prescriptions and compounded medication preparation. 2. Describe common compliance challenges in pharmacy compounding and strategies to avoid regulatory missteps.
0.05 CEU/0.5 Hr UAN: 0107-0000-25-273-H07-P Initial release date: August 18, 2025 Expiration date: August 18, 2026 Additional CPE details can be found here.
Multiple studies highlight the benefits of direct oral anticoagulants (DOACS) with lower incidence of side effects and non-inferiority to warfarin. Join host, Geoff Wall, and guest, Mathew Boyd, as they discuss the FRAILE AF study and whether warfarin may be the best bet in older adults.
The GameChanger: DOACs are recommended by nearly all relevant major medical guidelines as the anticoagulant of choice in atrial fibrillation. A new study has found that in frail elderly patients, warfarin may be associated with fewer bleeding episodes.
Host Geoff Wall, PharmD, BCPS, FCCP, BCGP Professor of Pharmacy Practice, Drake University Internal Medicine/Critical Care, UnityPoint Health
Guest Mathew Boyd, PharmD Clinical Pharmacist Unity Point
Reference Joosten LPT, van Doorn S, van de Ven PM,et al. Safety of Switching from a Vitamin K Antagonist to a Non-Vitamin K Antagonist Oral Anticoagulant in Frail Older Patients with Atrial Fibrillation: Results of the FRAIL-AF Randomized Controlled Trial. Circulation. 2023 Aug 27. doi: 10.1161/CIRCULATIONAHA.123.066485. Epub ahead of print. PMID: 37634130.
Learning Objectives Upon successful completion of this knowledge-based activity, participants should be able to: 1. Describe the design and results of the FRAIL AF study 2. Apply the results of the Groningen Frailty Index to a specific patient
0.05 CEU/0.5 Hr UAN: 0107-0000-23-302-H01-P Initial release date: 9/25/2023 Expiration date: 9/25/2024 Additional CPE details can be found here.
In this week's Level Up episode Ashlee speaks with CoraLynn Trewet who has the honor of being the first recipient of the Thomas R. Temple Mentorship Award from the Iowa Pharmacist Association. A testament to the transformative power of mentorship, CoraLynn’s journey is one of reciprocation, authenticity, and the profound impact of being truly seen. Join us as we traverse her inspiring journey and unlock insights into the essence of a meaningful mentorship.
CoraLynn emphasizes the importance of openness to receiving mentorship and the ripple effect of paying it forward. We also shed light on the undeniably joyous pride that blooms from a mentee's success, and the invaluable role of having varied mentors at different junctures of our careers. This episode promises a refreshing view on mentorship, highlighting the significance of forging connections with individuals who ignite our inspiration.
Later in the episode, CoraLynn shares her wisdom on the art of building authentic relationships. We dive into the subtleties of trust, authenticity, and vulnerability, and their pivotal role in fostering meaningful relationships. CoraLynn also gives valuable tips on being an exceptional mentor, from being an attentive listener to inspiring others to find answers within themselves. We wrap up with a discussion on the importance of making others feel seen and cherished, a sentiment that beautifully encapsulates CoraLynn's own mentorship journey.
Join us for this enriching conversation on the transformative power of meaningful mentorship.
Guidelines for Management of Post-Procedural Headache after Epidural Use
18 Sep 2023
00:22:34
Although uncommon, severe headaches, neck sitffness, and other symptoms may occur after epidural procedures (lumbar puncture). Join host, Geoff Wall, as he evaluates new guidelines for the management of these symptoms
The GameChanger Post procedural headache can be severe and last up to two weeks or longer. Management includes standard pain medications but may require caffeine or application of a blood patch to prevent dural leak.
Host Geoff Wall, PharmD, BCPS, FCCP, BCGP Professor of Pharmacy Practice, Drake University Internal Medicine/Critical Care, UnityPoint Health
Reference Uppal V, Russell R, Sondekoppam R, et al. Consensus Practice Guidelines on Postdural Puncture Headache From a Multisociety, International Working Group: A Summary Report. JAMA Netw Open. 2023;6(8):e2325387. doi:10.1001/jamanetworkopen.2023.25387
Learning Objectives Upon successful completion of this knowledge-based activity, participants should be able to: 1. Discuss with patients the risk factors and symptoms of post-procedural headache 2. Discuss pain management strategies for post-procedural headache
0.05 CEU/0.5 Hr UAN: 0107-0000-23-301-H01-P Initial release date: 9/18/2023 Expiration date: 9/18/2024 Additional CPE details can be found here.